Rani Therapeutics Holdings (RANI) Cash & Equivalents (2020 - 2026)
Rani Therapeutics Holdings' Cash & Equivalents came in at $53.4 million for Q2 2026, up 422.7% from $10.22 million a year earlier and up 23.0% from the prior quarter.
Powered by 
Analysis
Rani Therapeutics Holdings (RANI) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Rani Therapeutics Holdings' Cash & Equivalents was $18.62 million, up 394.9% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -23.9% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $3.76 million in FY2024 (-35.8%), $5.86 million in FY2023 (-78.3%), $27.01 million in FY2022 (-77.0%) and $117.45 million in FY2021 (+60.8%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q2 2022.
- Year-over-year, Cash & Equivalents has increased for three consecutive quarters, with growth averaging 158.4% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2026 (growth of 422.7%), and the weakest in Q2 2023 (a decline of 92.2%).
- Business Quant data shows RANI's Cash & Equivalents at $43.4 million (Q1 2026), $18.62 million (Q4 2025) and $4.14 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Rani Therapeutics Holdings | 149.73 Mn | 158.49 Mn | - | 53.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.40 Mn |
| Mar 31, 2026 | 43.40 Mn |
| Dec 31, 2025 | 18.62 Mn |
| Sep 30, 2025 | 4.14 Mn |
| Jun 30, 2025 | 10.22 Mn |
| Mar 31, 2025 | 10.11 Mn |
| Dec 31, 2024 | 3.76 Mn |
| Sep 30, 2024 | 4.28 Mn |
| Jun 30, 2024 | 4.51 Mn |
| Mar 31, 2024 | 6.88 Mn |
| Dec 31, 2023 | 5.86 Mn |
| Sep 30, 2023 | 4.97 Mn |
| Jun 30, 2023 | 7.55 Mn |
| Mar 31, 2023 | 18.98 Mn |
| Dec 31, 2022 | 27.01 Mn |
| Sep 30, 2022 | 27.22 Mn |
| Jun 30, 2022 | 97.18 Mn |
| Mar 31, 2022 | 107.84 Mn |
| Dec 31, 2021 | 117.45 Mn |
| Sep 30, 2021 | 129.74 Mn |
API Access
Rani Therapeutics Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RANI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();